Raymond James Financial, Inc. (RJF) is due to report earnings after the closing bell on October 19,...(read more
I went with my friend Cobb last weekend to an "investor breakfast". If you have never been to one, they are usually put on by a brokerage or money management firm and are geared towards...(read more
Endo Pharmaceuticals (NASDAQ: ENDP) was upgraded by Oppenheimer from “perform” to "outperform." ENDP's shares closed at $33.10 yesterday. Endo's quarterly earnings surged 72.38% y/y.
Jefferies upgraded Callon Petroleum Company...(read more